Centessa Pharmaceuticals (CNTA) Receivables - Other (2024 - 2026)
Centessa Pharmaceuticals (CNTA) reported Receivables - Other of $3.3 million for Q1 2026, up 143.97% year-over-year from $1.3 million in Q1 2025, and down 2.41% on a QoQ basis from $3.4 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 3 years of Receivables - Other data on file, last reported at $3.3 million in Q1 2026.
- Quarterly Receivables - Other rose 143.97% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 143.97% YoY) and the FY2025 annual result came in at $3.4 million, up 1070.73% from the prior year.
- Receivables - Other declined to $3.3 million in Q1 2026 per CNTA's latest filing, from $3.4 million in the prior quarter.
- Across five years, Receivables - Other topped out at $3.4 million in Q4 2025 and bottomed at $287000.0 in Q4 2024.
- The 3-year median for Receivables - Other is $2.1 million (2025), against an average of $2.1 million.
- The widest annual swing landed in 2025, when Receivables - Other jumped 1070.73%; it then soared 143.97% in 2026.
- Tracing CNTA's Receivables - Other over 3 years: stood at $287000.0 in 2024, then jumped by 1070.73% to $3.4 million in 2025, then fell by 2.41% to $3.3 million in 2026.
- Per Business Quant, the three latest CNTA Receivables - Other figures stand at $3.3 million (Q1 2026), $3.4 million (Q4 2025), and $1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.28 Mn |
| Mar 31, 2026 | 3.28 Mn |
| Dec 31, 2025 | 3.36 Mn |
| Dec 31, 2025 | 3.36 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 287,000.00 |
| Dec 31, 2024 | 287,000.00 |